Average Co-Inventor Count = 3.84
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Rhizen Pharmaceuticals Sa (36 from 51 patents)
2. Incozen Therapeutics Pvt. Ltd. (5 from 7 patents)
3. Rhizen Pharmaceuticals Ag (3 from 5 patents)
4. Icozen Therapeutics Pvt. Ltd. (0 patent)
39 patents:
1. 12428422 - Purine derivatives as SIK-3 inhibitors
2. 11858907 - Kinase modulators
3. 11466006 - Dual selective PI3 delta and gamma kinase inhibitors
4. 11066402 - 3,5-disubstituted-3H-imidazo[4,5-b]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of c-Met protein kinases
5. 11065236 - Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
6. 11020399 - Intermediates useful in the synthesis of compounds as modulators of protein kinases
7. 10851107 - Dual selective P13 delta and gamma kinase inhibitors
8. 10786504 - Method of treatment and compositions comprising a dual PI3K delta-gamma kinase inhibitor and a corticosteroid
9. 10668051 - Modulators of calcium release-activated calcium channel
10. 10611759 - Glutaminase inhibitors
11. 10590129 - 3,5-disubstituted-3H-imidazo[4,5-B]pyridine and 3,5-disubstituted-3H-[1,2,3]triazolo[4,5-B] pyridine compounds as modulators of protein kinases
12. 10538501 - Kinase modulators
13. 10442783 - 2,3-disubstituted chromen-4-one compounds as modulators of protein kinases
14. 10413532 - Pharmaceutical compositions containing a PDE4 inhibitor and a PI3 delta or dual PI3 delta-gamma kinase inhibitor
15. 10322130 - Substituted chromenones as modulators of protein kinases